Teva Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TEVA and other ETFs, options, and stocks.

About TEVA

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. 

CEO
Richard Francis
CEORichard Francis
Employees
33,346
Employees33,346
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
1901
Founded1901
Employees
33,346
Employees33,346

TEVA Key Statistics

Market cap
39.37B
Market cap39.37B
Price-Earnings ratio
27.81
Price-Earnings ratio27.81
Dividend yield
Dividend yield
Average volume
10.10M
Average volume10.10M
High today
$34.25
High today$34.25
Low today
$33.68
Low today$33.68
Open price
$33.91
Open price$33.91
Volume
5.01M
Volume5.01M
52 Week high
$37.35
52 Week high$37.35
52 Week low
$12.47
52 Week low$12.47

TEVA News

Simply Wall St 7d
Assessing Teva Pharmaceutical Industries Valuation After Recent Share Price Momentum And Biosimilar Growth Hopes

Advertisement Why Teva Pharmaceutical Industries (NYSE:TEVA) is on investors’ radar today Teva Pharmaceutical Industries (NYSE:TEVA) has drawn fresh attention...

Assessing Teva Pharmaceutical Industries Valuation After Recent Share Price Momentum And Biosimilar Growth Hopes

Analyst ratings

86%

of 14 ratings
Buy
85.7%
Hold
7.1%
Sell
7.1%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.